Skip to main content
MDLN
NASDAQ Life Sciences

Medline 股东完成 35 亿美元的二级发行，承销商完全行使认购权

feedReported by GlobeNewswire
Sentiment info
Neutral
Importance info
7
Price
$43.57
Mkt Cap
$57.238B
52W Low
$38
52W High
$50.876
Market data snapshot near publication time

summarizeSummary

Medline Inc. 宣布了一项二级发行的结束，在这次发行中，出售股份的股东，包括主要的私募股权公司，出售了 8625 万股 A 类普通股，每股价格为 41.00 美元，总计约 35.3 亿美元。这包括承销商完全行使了额外 1125 万股的认购权。这一事件标志着二级发行过程的完成，该过程最初于 3 月 3 日通过 S-1 登记并于 3 月 5 日定价。虽然 Medline 没有从销售中获得任何收益，但完全行使超额配售选择权表明市场对以发行价格出售股份有强劲的需求。这一公众持股量的显著增加可能会影响交易动态，但强劲的需求表明了潜在的投资者信心。

在该公告发布时，MDLN的交易价格为$43.57，交易所为NASDAQ，所属行业为Life Sciences，市值约为$572.4亿。 52周交易区间为$38.00至$50.88。 这则新闻被评估为中性市场情绪，重要性评分为7/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed MDLN - Latest Insights

MDLN
Apr 08, 2026, 9:20 AM EDT
Source: Reuters
Importance Score:
9
FDA Warns Medline Over Defective Heart Syringes, Citing Patient Harm and Failed Fixes
Sentiment: Negative
View Wiseek Article
MDLN
Mar 12, 2026, 8:01 PM EDT
Filing Type: 4
Importance Score:
7
Hellman & Friedman Entities Sell Over $1.14 Billion in Medline Shares
Sentiment: Negative
View Wiseek Article
MDLN
Mar 12, 2026, 4:30 PM EDT
Filing Type: 4
Importance Score:
7
Carlyle-Related Entities Sell Over $1 Billion in Medline Shares
Sentiment: Negative
View Wiseek Article
MDLN
Mar 12, 2026, 4:30 PM EDT
Filing Type: 4
Importance Score:
7
Carlyle Group Entities Report Over $1 Billion Sale of Medline Shares
Sentiment: Negative
View Wiseek Article
MDLN
Mar 12, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
Stephen A. Schwarzman and Blackstone Entities Dispose of Over $1.14 Billion in Medline Inc. Shares
Sentiment: Negative
View Wiseek Article
MDLN
Mar 12, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
Blackstone-Affiliated Entities Sell Over $1.1 Billion in Medline Shares
Sentiment: Negative
View Wiseek Article
MDLN
Mar 10, 2026, 2:00 PM EDT
Source: GlobeNewswire
Importance Score:
7
Medline Shareholders Complete $3.5B Secondary Offering, Underwriters Fully Exercise Option
Sentiment: Neutral
View Wiseek Article
MDLN
Mar 06, 2026, 4:01 PM EST
Filing Type: 424B4
Importance Score:
8
Major Shareholders Finalize $3.075 Billion Secondary Offering at Discounted Price
Sentiment: Negative
View Wiseek Article
MDLN
Mar 04, 2026, 8:00 PM EST
Source: Reuters
Importance Score:
8
Medline Shareholders Price 75M Share Secondary Offering at $41.00
Sentiment: Negative
View Wiseek Article
MDLN
Mar 03, 2026, 7:02 AM EST
Source: GlobeNewswire
Importance Score:
8
75 Million Medline Shares Offered by Private Equity Backers in Secondary Sale
Sentiment: Negative
View Wiseek Article